Atlas Trials

Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II Study

Clinical trial NCT02424916 · COMPLETED

Trial details

NCT number
NCT02424916
Sponsor
Nantes University Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Melanoma
Start date
2015-05-26
Primary completion
2019-05-06
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.